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Abstract
Pancreatic ductal adenocarcinoma (PDAC) is known for its early spreading of tumor
cells  into  the  liver.  The  aim of  this  study was  to  investigate  the  modulated gene
expression  of  PDAC  cells  during  liver  colonization.  To  that  purpose,  ASML  rat
pancreatic cancer cells marked with enhanced green fluorescent protein were inoculat‐
ed into the portal vein of isogenic BDX rats and reisolated from livers by fluorescence-
activated cell sorting sorting at early (1, 3 days), intermediate (9 days), advanced (15
days), and terminal (21 days) stages of liver colonization. Reisolated ASML cells were
used for total RNA isolation and subsequently their gene expression was investigated
by Illumina chip array for mRNA and miRNA species, followed by Ingenuity Pathway
Analysis (IPA). Following reisolation, 7–20% of genes and 10% of miRNA species were
modulated significantly in expression during the early stage of liver colonization and
continuously thereafter. These overall changes led to distinguish certain categories and
processes participating in cancer progression. The knowledge of these alterations in
gene expression will suggest targets, which could be used for new diagnostic proce‐
dures as well as for combating liver metastasis successfully.
Keywords: pancreatic cancer, liver metastasis, ASML cells, isogenic rat model, modu‐
lation of gene expression, stages of liver colonization
1. Introduction
Pancreatic ductal adenocarcinoma (PDAC) is an extremely aggressive cancer [1, 2], as derived
from the respective 5-year survival rate of about 6% [3, 4]. This poor prognosis results, at least
in part, from a delayed diagnosis of the disease. All therapeutic efforts during the past 50 years,
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such as surgery, radiation therapy, chemotherapy, or combinations thereof, have shown little
impact on the course of this aggressive neoplastic disease. It is hoped, however, that a full
understanding of the molecular biology of pancreatic cancer will help in diagnosing, prevent‐
ing, and treating this cancer.
A most recent study on pancreatic cancer patients describes genetic details, which have been
detected through full genome sequencing and copy number analyses in 100 PDACs. Genetic
drivers known for pancreatic cancer, such as K-ras, TP53, SMAD4, and mutations in CDKN2A,
were confirmed, whereas newly identified mutations, such as in the KDM6A gene, highlighted
the role of chromatin modifications [5]. Based on familial clustering studies, it was estimated
that 10% of PDAC cases are linked to an inherited predisposition [4, 6, 7]. Germ line mutations
were especially found in tumor suppressor genes, such as INK4A, BRCA2, and LKB1, the
mismatch repair gene MLH1, and the cationic trypsinogen gene PRSS1 [8, 9]. These germ line
mutations are responsible for onset and penetrance of PDAC, but they likely contribute more
to the malignant progression of precursor lesions than to cancer initiation [10, 11]. Of course,
exogenous factors, such as cigarette smoking, constitute a measurable risk, as well [12].
In the early stage of PDAC, the genetic mutations of oncogenes like K-ras and suppressor genes
like TP53—or both—lead to constitutive activation of transcription factors, but in the late stage
stress factors such as acidosis and hypoxia, which are frequently encountered in the tumor
microenvironment, further deregulate the expression of metastasis-related proteins. PDAC
metastasis is a progressive, debilitating disease that is characterized by pain, asthenia,
anorexia, and cachexia. The formation of metastasis is a complex and progressive process,
including four basic steps: dissociation of cells from the primary tumor, existence and survival
in the circulatory system, break down and degrading of endothelium and basement mem‐
branes in target organs, and (d) establishment of a colony of metastatic cells [13].
Currently, it is hoped that new findings related to K-ras, the tumor’s unique metabolic needs,
and how the stroma and immune system affect the PDAC, will change the overall situation
for the better [14].
In order to better understand the PDAC metastatic process, a liver metastasis model was
developed by our group [15]. This model focused on the final steps of metastasis, which are
related to organ colonization. To that purpose, ASML rat PDAC cells, which had been marked
by luciferase (ASMLluc [15]) were implanted intraportally into isogenic BDX rats for mimicking
the final phase of liver metastasis. This process of liver colonization was related to the size of
the liver and the remaining life span of a given animal. Thus, for reisolation of tumor cells from
rat liver, four periods were selected and classified as early (days 1, 3), intermediate (day 6),
advanced (day 15), and terminal (day 21) stages. Also, tumor cells were recultivated in vitro
after their reisolation at 21 days for three additional periods (3, 6, and 9 days) to define the
microenvironment effect on gene expression after residing 21 days in rat liver. Reisolated
ASML tumor cells were used for total RNA isolation and then investigated by Illumina chip
array for genes and miRNAs, which show modulation of their expression during liver
colonization. These modulations were evaluated by Ingenuity Pathway Analysis (IPA) as
described in the study of Al-Taee et al. [16].
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The aim of this study was to establish a rat model for identifying and understanding patho‐
physiological processes during metastatic liver colonization, as well as for finding new and
specific tumor markers as tools for diagnostic and therapeutic approaches. Here, we report on
the modulation of gene expression during stages of liver colonization by ASML pancreatic
cancer cells in rat liver.
2. Gene expression modulation in ASML rat PDAC cells during liver
colonization
2.1. Reisolation of tumor cells from liver tissue
ASML cells, which had been implanted to BDX rats, were reisolated after various periods. The
purity of these cells was based on a procedure, which involved gradient centrifugation as first
step followed by FACS sorting of eGFP-labeled tumor cells. Pending on the number of tumor
cells, the final grade of purity varied from 90% (day 1) to 99% (day 15) based on 1.6 to 52% of
tumor cells present in the cell suspension after gradient centrifugation.
2.2. mRNA modulation of ASML cells colonizing rat liver
2.2.1. Fold changes in mRNA expression
In order to analyze the mRNA modulation, which occurs in ASML pancreatic cancer cells
colonizing the rat liver, the gene expression profiles of ASML cells were determined by
microarray in five batches of tumor cells that had been reisolated from rat liver after 1, 3, 6, 15,
and 21 days post injection into the portal vein. For each of the five batches, representing
different stages of liver colonization, 23,400 genes were analyzed in total. In an attempt to
categorize the observed changes in gene expression, two parameters were chosen initially: the
fold change in mRNA expression over that of respective genes in control ASML cells growing
in vitro, and the time until reisolation of tumor cells from rat liver. The gene expression profile
from cells isolated after days 1 and 3 was classified as reflecting early colonization, as no tumor
burden was visible with naked eye. On day 6, the ASML cells showed signs of infiltrative
growth in the rat liver, visible as white spots of 1–2 mm in diameter and were discernible
macroscopically. The corresponding gene profile was classified as intermediate colonization.
At 15 days post injection, the ASML cells colonized about 40% of the rat liver and the tumor
spot size increased to ~5 mm in diameter. The respective gene expression profile was consid‐
ered as advanced colonization. At 21 days post injection, ASML cells almost completely
infiltrated the rat liver and the corresponding gene expression profile was classified as terminal
stage. An overview for the two categories, the fold changes in mRNA expression and the
respective stage of liver colonization, is shown in Figure 1.
The observed modulation ranged from more than 2-fold to more than 20-fold, with a similar
distribution pattern regarding decreased and increased levels, thus resulting in a curve
resembling a normal (Gaussian) distribution. This distribution was similarly bell shaped over
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all stages, thus indicating little overall variation between early and late colonization stages.
There was one exception, however, regarding mRNAs with more than 20-fold increased or
decreased levels: the former were distinctly more prevalent than the latter at the early stage,
thus indicating a possible need for the strong activation of genes initially after tumor cell
implantation.
Figure 1. mRNA modulation in rat pancreatic cancer cells colonizing rat liver: Given is the fold change of mRNA ex‐
pression of reisolated ASML cells during early, intermediate, advanced, and terminal stages of liver colonization rela‐
tive to control cells growing in vitro.
2.2.2. Types of mRNA modulation
On a single gene level, several types of modulation were found during the different stages of
colonization. Some examples are shown in Figure 2.
These included a steady increase in expression of certain genes, as seen for matrix metallo‐
proteinase-2 (MMP-2) and ephrin type-A receptor 8 (Epha8), as well as a steady decrease, as
observed for cadherin 11 (Cdh11) and 5-hydroxytryptamine (serotonin) receptor 5B (Htr5b)
(see Figure 2A).
Another type, typical of an immediate increase or decrease in gene expression followed by a
persistent plateau was observed as well. This type of modulation was seen for the expression
levels of claudin-1 (Cldn1) and insulin-like growth factor 2 (IGF2), which showed a sustained
increase, whereas transforming growth factor alpha (TGF-α) and MDM2 proto-oncogene/E3
ubiquitin protein ligase (Mdm2) showed a sustained decrease (see Figure 2B).
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A third type of altered gene expression was classified as early type responsive gene (e.g.
insulin-like growth factor binding protein 2 (Igfbp2) and keratin, type I cytoskeletal 42 (Krt42))
or late type responsive gene (e.g. lipolysis-stimulated lipoprotein receptor (Lsr) and family
with sequence similarity 132, member A (Fam132a)), which was either activated greatly in the
early stages of colonization and later showed a somewhat reduced expression or they started
with a mildly increased expression level and showed intensely increased expression only at
the end of the colonization period (see Figure 2C).
Figure 2. Types of gene expression modulation found during the different stages of liver colonization: given are exam‐
ples of steady increases in expression (A), immediate increases or decreases in gene expression followed by a persis‐
tent plateau (B), and early or late type responsive genes (C).
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Table 1. Some categories and related diseases or functions annotations.
2.2.3. Categories of the tumor cell genome showing modulation
By Ingenuity Pathway Analysis (IPA), a more comprehensive way of categorizing altered gene
expression was realized. In this analysis, several possibilities of grouping or ordering genes
were followed. Initially, some general cellular categories were chosen, which encompass a
limited number of more specific disease or function annotations. These, in turn, are charac‐
terized by a distinct number of genes participating in the disease or function. The overall status
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of these genes (i.e. increased in expression or decreased in expression) is used to coin an
activation z-score, which is considered significant if higher than 2 (i.e. activated) or lower than
−2 (decreased). In addition, a p value indicates the significance of the alteration of the respective
process (Table 1).
Based on this analysis, the category “cellular movement” with the two function annotations
“cell movement of mononuclear leukocytes” and “migration of phagocytes” with 121 and 80
genes, respectively, was significantly increased at early and terminal stages, but not signifi‐
cantly altered at intermediate and advanced stages. This is surprising, as it shows that
movement or migration of cells is not equally important over the whole colonization period.
Although this category of genes is increased initially, soon thereafter it is deactivated and
reactivated only for the terminal stage (Table 1, top part, column 1).
Another example is the category of genes related to proliferation. As could be expected, genes
belonging to this category were augmented in expression initially, as derived from the
significantly increased activation z-score (2.44), but failed to show activation at intermediate
and advanced stages. At these stages, genes related to neuronal cell proliferation were even
decreased in expression or showed no activation. At the terminal stage, there was activation
of genes related to the proliferation of fibroblasts, but not of genes related to proliferation of
neuronal cells (Table 1, top part, column 2).
Genes related to the growth of connective tissue, fatty acid metabolism, M-phase of tumor cell
lines, and quantity of myeloid cells were mainly upregulated but not throughout the whole
liver colonization process. In addition, genes related to the immune response, phagocytosis,
and invasion were decreased in activation (Table 1, top and bottom parts, columns 3–9).
2.2.4. Modulation of acute phase signaling chain genes
Subsequently, Ingenuity Pathway Analysis (IPA) was used for overlaying the findings of this
study onto scaffolds of known genetic relationships. This included a scaffold for the genes of
the acute phase signaling chain, which was overlaid with gene expression levels obtained at
intermediate (day 6 after tumor cell implantation, Figure 3A) and terminal (day 21 after tumor
cell implantation, Figure 3B) stages.
These figures show a differentiation of genes according to cellular compartments as well as to
colors as indicator of expression levels. Symbols, which have been placed to the specific cellular
or extracellular sites of the respective proteins, are used to report on a specific gene expression.
A colored border line of the respective symbol indicates that data from the present analysis
were available to describe the status of the gene. The colors used for filling the symbol denote
differences in expression: red color indicates increased expression and green color indicates
decreased expression, with less intense colors hinting to less pronounced increased or
decreased expression.
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Figure 3. A) Overlay of ASML cell gene expression (day 6) on acute phase signaling chain. B) Overlay of ASML cell
gene expression (day 21) on acute phase signaling chain.
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On day 6 after tumor cell implantation, two genes (albumin and transferrin) of the acute phase
signaling chain are highlighted in intense red color and three genes (interleukin 6, α-2-
macroglobulin, and ceruloplasmin) in intense green color. Fifteen more genes are shown by
red colors of lower intensity, indicating submaximally increased expression levels. In addition,
14 genes are highlighted in a green color of reduced intensity, indicating less than maximally
decreased expression (see Figure 3A).
At the terminal stage, eight genes (albumin, transferrin, α-1-microglobulin, fibrinogen alpha
chain, serpin family A member 3, inter-alpha-trypsin inhibitor heavy chain H3, inter-alpha-
trypsin inhibitor heavy chain H4, and coagulation factor II (thrombin)) were highlighted in
the most intense red color and 21 more genes in less intense red colors. Concomitantly, only 1
gene (interleukin 6) was highlighted in intense green color and 15 in less intense green colors
(see Figure 3B), indicating a shift from reduced expression of acute phase signaling genes at
the intermediate stage to increased expression at the terminal stage of liver colonization.
2.2.5. Modulation of metastasis associated genes
In addition to using genes of the acute phase signaling as scaffold, another overlay of was
done by IPA analysis at the terminal stage of liver colonization for the three signaling cas‐
cade scaffolds known as “metastatic solid tumor,” “metastasis,” and “metastatic gastrointes‐
tinal tract cancer” (Figure 4). Because of the large overlap between the corresponding genes,
all three scaffolds were combined in one scheme, resulting in a picture, in which the three
scaffold designations are connected with their respective genes by straight lines. For clarity,
the gene symbols are arranged according to their cellular site, i.e. extracellularly, in the plas‐
ma membrane, in the cytoplasm, or in the nucleus. In addition to the red/green color
scheme known from Figure 3A and B, the straight lines are colored by yellow and blue col‐
ors, which indicate activation or inhibition of the respective gene products activity. Thus,
very often a gene highlighted in a reddish color, which indicates increased expression over
control, will be connected with its scaffold designation by a yellow line, indicating activa‐
tion of the respective group of genes as given for the scaffold designation “metastatic solid
tumor” and the gene expression of collagen, type IV, alpha 2 (Col4a2), or of coagulation
factor II, thrombin (F2). This means that the increased expression of Col4a2 or F2 predicts
activation of a significant share of related genes. Conversely, a gene highlighted in green
color, which indicates decreased expression versus control, is sometimes connected with its
scaffold designation by a straight blue line, indicating inhibition of the respective group of
genes, as given for the scaffold designation “metastatic solid tumor” and the gene expres‐
sion of colony stimulating factor 1 (Csf1) or interleukin 6 (IL-6). This means that the de‐
creased expression of Csf1 or Il6 predicts inhibition of a significant share of related genes.
In addition, a gene symbol colored reddish can be connected to the scaffold designation by a
yellow line, indicating that its increased expression is related to inhibition of the corresponding
gene group, as for the genes apolipoprotein A1 (Apoa1) and serpin family E member 1
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(Serpine1). This means that the increased expression of APOA1 or Serpine1 predicts inhibition
of a significant share of related genes. Finally, a gene symbol colored greenish can be connected
to the scaffold designation by an orange line, as for the genes superoxide dismutase 3 (Sod3)
and TIMP metallopeptidase inhibitor 1 (Timp1). This implies that the decreased expression of
Sod3 or Timp1 predicts activation of a significant share of related genes (Figure 4A).
As Figure 4A gives an overview on a multitude of genes being connected to the three signal‐
ing cascade scaffolds known as “metastatic solid tumor,” “metastasis,” and “metastatic gas‐
trointestinal tract cancer,” which allowed to show less details, a more complete description
of a selection of metastasis genes is given in Figure 4B. This figure shows the respective fold
changes in mRNA levels versus control as positive or negative numbers below the corre‐
sponding gene symbols.
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Figure 4. A) Overlay of ASML cell gene expression (day 21) on the three signaling cascade scaffolds termed “metastatic
solid tumor,” “metastasis,” and “metastatic gastrointestinal tract cancer.” The three scaffold designations are connect‐
ed with their respective genes by straight lines. For clarity, the gene symbols are arranged according to their cellular
site, i.e. extracellularly, in the plasma membrane, in the cytoplasm, or in the nucleus. In addition to the red/green color
scheme known from Figure 3A and B, the straight lines are colored by yellow and blue colors, which indicate activa‐
tion or inhibition of the respective related genes. B) More detailed description of a selection of metastasis genes. The
respective fold changes in mRNA levels versus control are given as positive or negative numbers below the corre‐
sponding gene symbols.
2.2.6. Role of upstream regulators
The third IPA analysis concentrated on upstream regulators, which showed a significant
modulation in expression and therefore altered the activation state of a whole series of
downstream proteins.
From the early stage of liver colonization, six genes were selected for detailed analysis. These
included member RAS oncogene family-like 6 (Rabl6), which was increased in expression and
caused significant activation of downstream target genes, as well as Ras association domain
family member 1 (Rassf1), nuclear protein, transcriptional regulator, 1 (Nupr1), and jun proto-
oncogene (Jun), which also showed increased expression but caused inhibition of the corre‐
sponding downstream molecules (Table 2). Finally, the genes interleukin 1 alpha (Il1a) and
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inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma (Ikbkg) showed
decreased expression and caused inhibition of their respective downstream molecules (see
Table 2).
Rabl6, member RAS oncogene family-like 6; Rassf1, Ras association domain family member 1; Nupr1, nuclear protein,
transcriptional regulator, 1; Jun, jun proto-oncogene; Il1a, interleukin 1 alpha; and Ikbkg, inhibitor of kappa light
polypeptide gene enhancer in B-cells, kinase gamma.
Table 2. Shortlist of significantly modulated upstream regulators during the early stage of ASML cell rat liver
colonization.
From the intermediate stage of liver colonization, also six genes were selected for detailed
analysis. These genes included colony stimulating factor 2 (Csf2) and NK2 homeobox 3
(Nkx2-3), which showed decreased expression, but activated their respective downstream
molecules. The transcription regulator forkhead box M1 (Foxm1) was increased in expres‐
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sion and activated the corresponding downstream genes. The genes cytochrome P450, fami‐
ly 2, subfamily e, polypeptide 1 (Cyp2e1), angiotensinogen (Agt), and secreted
phosphoprotein 1 (Spp1) showed increased expression but inhibited their corresponding
downstream genes (see Table 3).
Csf2, colony stimulating factor 2; Nkx2-3, NK2 homeobox 3; Foxm1, forkhead box M1; Cyp2e1, cytochrome P450,
family 2, subfamily e, polypeptide 1; Agt, angiotensinogen; and Spp1, secreted phosphoprotein 1.
Table 3. Shortlist of significantly modulated upstream regulators during the intermediate stage of ASML cell rat liver
colonization.
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From the advanced stage of liver colonization, four genes were selected for detailed analysis.
These genes included Versican (Vcan), which showed a reduced expression but activated its
downstream genes, as well as myelocytomatosis oncogene (Myc), which exhibited increased
expression and also activated a considerable number of downstream genes. The genes
CCAAT/enhancer-binding protein beta (Cebpb) and transforming growth factor, beta 1
(Tgfb1), on the other hand, were reduced in expression and as a result inhibited their respective
genes (Table 4).
Vcan, Versican; Myc, myelocytomatosis oncogene; Cebpb, CCAAT/enhancer-binding protein beta; and Tgfb1,
transforming growth factor, beta 1.
Table 4. Shortlist of significantly modulated upstream regulators during the advanced stage of ASML cell rat liver
colonization
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Csf2, colony stimulating factor 2; Foxm1, forkhead box M1; Tsc2, tuberous sclerosis 2; and Tnf, tumor necrosis factor.
Table 5. Shortlist of significantly modulated upstream regulators during the terminal stage of ASML cell rat liver
colonization.
From the terminal stage of liver colonization, again four genes were selected for detailed
analysis. These included two genes, which had been listed before (Csf2 and Foxm1) that caused
the same pattern of expression and resulting influence as in the intermediate stage of liver
Modulation of Gene Expression During Stages of Liver Colonization by Pancreatic Cancer in a Rat Model
http://dx.doi.org/10.5772/64335
121
colonization (decreased expression but subsequent activation in the case of Csf2 and increased
expression resulting in subsequent activation in the case of Foxm2). The other two regulators
(tuberous sclerosis 2 (Tsc2) and tumor necrosis factor (Tnf)) were both increased in expression
and were predicted to inhibit a large number of downstream genes (see Table 5).
2.3. Changes in mRNA expression after recultivation in vitro
For assessing the influence of the environment on ASML tumor cells, ASML cells were also
recultivated in vitro for 3, 6, and 9 days after they had been reisolated from rat liver after a
colonization period for 21 days. As a result, genes were found to be downregulated in vitro or
upregulated at varying degrees. Some examples are given in Figure 5. As can be seen, the genes
desmoglein 4 (Dsg4), tRNA methyltransferase 10A (Trmt10a), and stathmin 2 (Stmn2) were
decreased more than 1000-fold, more than 100-fold, and more than 3-fold, respectively. In
contrast, the genes apolipoprotein C-II (Apoc2), ectonucleotide pyrophosphatase/phospho‐
diesterase 1 (Enpp1), and Keratin 18 (Krt18) were increased more than 3-fold (Apoc2 and
Enpp1) and more than 100-fold (Krt18). The differences between the cultivation periods of 3,
6, and 9 days were very low and thus negligible.
Figure 5. Changes in mRNA expression after recultivation in vitro: ASML cells were also recultivated in vitro for 3, 6,
and 9 days after they had been reisolated from rat liver after a colonization period for 21 days. As a result, some genes
were downregulated or upregulated in vitro, at varying degrees. Seven examples are given in comparison to control.
2.4. miRNA modulation of ASML cells colonizing rat liver
Concomitantly with the mRNA species, all known miRNA molecules were analyzed in the
respective batches of reisolated ASML cells. As for the distribution of mRNAs, the modulation
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of miRNA expression was detailed for the two same categories, i.e. the fold changes in miRNA
expression and the respective stage of liver colonization, as shown in Figure 6.
Figure 6. miRNA modulation of rat pancreatic cancer cells colonizing rat liver: Given is the fold change of mRNA ex‐
pression of reisolated ASML cells during early, intermediate, advanced, and terminal stages of liver colonization rela‐
tive to control cells growing in vitro.
Because of the lower number of existing miRNAs as compared to mRNAs, the distribution
looks not as bell shaped as for mRNAs in Figure 1. This is also due to a considerable number
of miRNAs, which show a more than 20-fold regulation (both, positive and negative) in the
terminal stage of liver colonization.
An example for the influence of miRNAs is given in Figure 7. The miRNA 29b-3p is known
for its effect on extracellular matrix proteins, as on collagens [17]. Downregulation of miRNA
29b-3p was observed in ASML cells during the whole period of liver colonization. This is
shown in Figure 7A, with the nadir of miRNA 29b-3p expression appearing on day 3 (less than
10-fold of control level), and some recovery thereafter to a plateau of expression ranging from
fivefold to threefold reduced levels, as related to control expression in vitro. This reduction
was associated with distinctly increased expression of the collagens Col4a2 (collagen, type IV,
alpha 2), Col3a2, Col1a2, Col1a1, and Col4a1. Col5a3 showed only a minor increase in
expression, but Col5a2 (collagen, type V, alpha 2) showed reduced expression, as was true for
Tgfb3 (transforming growth factor, beta 3) (Figure 7B).
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Figure 7. Influence of miRNA 29b-3p on gene expression: Shown is the expression of miRNA 29b-3p in ASML cells
during liver colonization (A). In addition, the influence on mRNAs is given in terms of upregulation or downregula‐
tion (B). For color code, see Figure 3.
This analysis shows that certain extracellular matrix proteins, as the collagen family, are highly
regulated by their respective miRNA. Further experiments are needed to reveal the mecha‐
nistic role of these proteins during liver colonization and to address the question whether they
can be diagnostic or therapeutic targets.
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